SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Send an e-mail with your comments!
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
TODAY'S NEWS
Gene clue to male heart disease
Wed June 19th - New links have been found between the male Y chromosome and risk of heart disease. More
RECENT COMMENTS
On 13/05/2013 RAS wrote:
Is this what it really shows? My blog comment ... on Peppers could protect against ...
On 18/04/2013 Editor wrote:
Comment from the Royal College of Midwives: Jacque... on Light drinking in pregnancy no...
On 02/02/2013 Mark wrote:
A total ban on these is long overdue. http://epet... on Teenagers beating sunbed ban...
On 01/02/2013 Paul wrote:
Being a veggie singleton yesterday's story seemed... on Marriage reduces heart attack ...
On 23/01/2013 vitamins and supplements wrote:
As in current era everyone is much aware about own... on Antidepressants prescribed "to...
OTHER NEWS FEEDS OF INTEREST
HEALTHY EATING BOOKS
ENGLEMED HEALTH NEWS

MS patients get "no benefit" from fish oil

Tuesday April 17th, 2012

A study of supplements for multiple sclerosis has found no beneficial effect from fish oils - omega-3 fatty acids, researchers report today.

Multiple sclerosis is a chronic disease that causes inflammation of the central nervous system and mainly affects young adults. Because of the incurable nature of the condition, there has been great interest in complementary approaches, for example, omega-3 fatty acid supplements which could help reduce the inflammation.

Dr Oivind Torkildsen of Haukeland University Hospital in Norway, and colleagues, looked at the potential benefit by giving 92 adult patients either a placebo or daily omega-3 fatty acid supplements (1,350mg of eicosapentaenoic acid and 850 mg of docosahexaenoic acid).

Six months into the study, all received an additional treatment of 44 micrograms of interferon beta-1a, three times a week for 18 months. This is an established drug that helps reduce the chance of relapse.

During the first six months, both groups scored similarly on disease activity. There was also no difference in the rate of relapse after six months or after the full 24 months. The rate of disability progression was 30 per cent in both groups.

Furthermore, no differences were seen in fatigue or quality of life, despite a measurable increase in the patients' levels of omega-3 fatty acids when taking the supplements.

Writing in the journal Archives of Neurology, the authors conclude: "No beneficial effects on disease activity were detected from omega-3 fatty acids when compared with placebo as monotherapy or in combination with interferon beta-1a."

They add that disease activity as seen on magnetic resonance imaging (MRI) scans "was reduced as expected by interferon beta-1a".

Omega-3 Fatty Acid Treatment in Multiple Sclerosis (OFAMS Study): A Randomized, Double-Blind, Placebo-Controlled Trial. Torkildsen, O. et al. Archives of Neurology April 16 2012 doi:10.1001/archneurol.2012.283

Tags: Alternative Therapy | Brain & Neurology | Diet & Food | Europe

Printer friendly page Printer friendly page

CATEGORIES